Tag
Hamilton
Mar 25, 2024
OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for up to US $2.4 billion
OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for up to US $2.4 billion
Sep 14, 2022
<strong>New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals</strong>
New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals
Nov 20, 2019
Study of Ontario health data offers new directions in sarcoma research and treatment
Study of Ontario health data offers new directions in sarcoma research and treatment
Nov 18, 2019
Potential new approach to T-cell therapy shows early promise in the lab
Potential new approach to T-cell therapy shows early promise in the lab
Sep 30, 2019
Hamilton study discovers new approach to target cells at the root of leukemia
Hamilton study discovers new approach to target cells at the root of leukemia
Sep 10, 2018
Researchers find unexpected cells at the centre of recurrent leukemia
Researchers find unexpected cells at the centre of recurrent leukemia
Aug 02, 2018
Ontario centre attracts national attention for probe research, development and commercialization
Ontario centre attracts national attention for probe research, development and commercialization
Apr 09, 2018
Biostatistics Training Initiative boosts Ontario's cancer research community
Biostatistics Training Initiative boosts Ontario's cancer research community
Dec 04, 2017
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
Oct 20, 2017
Old drug, new trick: study finds common diabetes drug could help fight leukemia
Old drug, new trick: study finds common diabetes drug could help fight leukemia
Oct 11, 2017
Ontario start-up makes major deal to develop cancer-fighting viruses
Ontario start-up makes major deal to develop cancer-fighting viruses
Sep 06, 2017
Innovative study brings next-generation genomic sequencing to more Ontario cancer patients
Innovative study brings next-generation genomic sequencing to more Ontario cancer patients
Aug 17, 2017
New genes discovered regulating brain metastases in lung cancer
New genes discovered regulating brain metastases in lung cancer
May 03, 2017
Study bringing more precision medicine to Ontario’s cancer patients
Study bringing more precision medicine to Ontario’s cancer patients
Apr 26, 2017
Clinical trial opens for promising combination therapy
Clinical trial opens for promising combination therapy
Aug 17, 2016
New retrospective study aims to identify mutations to better diagnose breast cancer in the future
New retrospective study aims to identify mutations to better diagnose breast cancer in the future
Jul 04, 2016
OICR congratulates Drs. Mark Levine, Eduardo L. Franco and Gerald Batist, new recipients of the Order of Canada
OICR congratulates Drs. Mark Levine, Eduardo L. Franco and Gerald Batist, new recipients of the Order of Canada
Jun 01, 2016
Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management
Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management
May 05, 2016
A new method to grow stem cells for cancer patients
A new method to grow stem cells for cancer patients
Mar 16, 2016
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
Feb 26, 2016
Biostatistics Training Initiative Kick Off
Biostatistics Training Initiative Kick Off
Dec 16, 2015
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
Nov 09, 2015
FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership
FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership